Intuitive Surgical (NASDAQ: ISRG) reported Q4 EPS of $2.21, $0.46 better than the analyst estimate of $1.75. Revenue for the quarter came in at $2.41 billion versus the consensus estimate of $2.2 billion.

2025 Financial Outlook
The Company expects the following results for the full year of 2025:
•The Company expects worldwide da Vinci procedures to increase approximately 13% to 16% in 2025 as compared to 2024. Worldwide da Vinci procedure growth was 17% in 2024 as compared to 2023.
•The Company expects non-GAAP* gross profit margin to be within a range of 67% and 68% of net revenue in 2025, compared to 69.1% in 2024. This range does not include any potential impact of new tariffs on our business, which could be material.
•The Company expects non-GAAP* operating expense growth to be within a range of 10% to 15% in 2025, compared to 10% in 2024.

For earnings history and earnings-related data on Intuitive Surgical (ISRG) click here.